Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP

Medexus Pharmaceuticals Inc (MDP) Ownership - Who Owns Medexus Pharmaceuticals Inc?

40 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 03, 2024
Brendon Buschman
Senior Officer
xxxxxxxxxxxxx
C$26220
Jun 29, 2024
Kenneth D'entremont
Chief Executive Officer
xxxxxxxxxxxxx
C$10750
Feb 14, 2024
Benoit Gravel
Non Executive,director
xxxxxxxxxxxxx
C$5408

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
20,588,235Insider84.18%45,499,999
18,715,744Insider76.52%41,361,794
10,368,420Insider42.39%22,914,208
3,700,000Insider15.13%8,177,000
2,683,784Insider10.97%5,931,163
2,563,744Insider10.48%5,665,874
1,467,869Insider6.00%3,243,990
1,273,518Insider5.21%2,814,475
921,080Insider3.77%2,035,587
547,080Insider2.24%1,209,047

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
135,100Institution0.55%216,836

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Medexus Pharmaceuticals Inc (TSE:MDP)?
Currently, no data Available
What percentage of Medexus Pharmaceuticals Inc (TSE:MDP) stock is held by institutional investors?
Currently, no data Available
What percentage of Medexus Pharmaceuticals Inc (TSE:MDP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Medexus Pharmaceuticals Inc (TSE:MDP)?
Gerard Marcel Leduc owns the most shares of Medexus Pharmaceuticals Inc (TSE:MDP).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis